Shockwave Therapy for ED Success Rate
Erectile dysfunction (ED) affects an estimated 30–50 million men in the United States, yet many patients remain dissatisfied with traditional treatment options. Oral medications such as PDE-5inhibitors (Viagra and Cialis) can improve performance temporarily, but they do not address the underlying vascular pathology responsible for erectile dysfunction in most men. Additionally, over time, some men become less responsive to oral medications such as Viagra and Cialis.
Over the past decade, Low-Intensity Shockwave Therapy (LiSWT) has emerged as one of the most studied regenerative treatments for vasculogenic ED, the most common type of ED associated with age. A common question patients ask is:
“What is the success rate of shockwave therapy for erectile dysfunction?”
The answer requires nuance because outcomes depend heavily on patient selection, disease severity, and treatment protocol. This article reviews what high-quality clinical evidence shows about shockwave therapy success rates.
Understanding the Mechanism:
Why Shockwave Therapy Works
Low-Intensity Shockwave Therapy delivers controlled acoustic energy waves to the penile tissue. Unlike high-energy shockwaves used for kidney stones, LiSWT operates at energy levels that stimulate biological repair rather than tissue destruction.
Research demonstrates several physiologic effects:
Induction of angiogenesis (new blood vessel formation)
Recruitment of endothelial progenitor cells (stem cell response in blood vessels)
Upregulation of nitric oxide signaling (blood vessel dilating chemicals)
Improved penile blood flow and endothelial function
Tissue remodeling at the microvascular level
Because approximately 70–80% of erectile dysfunction is vascular in origin, shockwave therapy targets the root cause rather than bypassing it pharmacologically. You can learn more on our Shockwave Therapy page.
Defining “Success” in Erectile Dysfunction Studies
Before discussing percentages, it is important to clarify how success is measured in clinical trials.
Most studies evaluate outcomes using validated instruments such as:
IIEF-EF (International Index of Erectile Function - Erectile Function domain)
Erection Hardness Score (EHS)
Ability to achieve penetration without medication
Reduction or elimination of PDE-5 inhibitor dependence
In the medical literature, success typically means:
A clinically meaningful improvement in erectile function is sufficient for satisfactory intercourse.
Shockwave Therapy for ED Success Rate:
What Clinical Studies Show
Overall Success Rates:
Across randomized controlled trials and meta-analyses, the average success rate ranges from 60% to 80% in appropriately selected patients.
Key findings from peer-reviewed research include:
Meta-analyses of randomized trials consistently show significant improvement compared with sham treatment.
Improvements are most pronounced in men with mild to moderate vasculogenic ED.
Benefits often persist 6–24 months after treatment.
A large pooled analysis published in European Urology demonstrated that men receiving LiSWT experienced statistically significant increases in IIEF-EF scores compared with placebo controls.
Success Rate by ED Severity:
Mild ED: 75–85% improvement
Mild–Moderate ED: 65–75% improvement
Moderate ED: 50–65% improvement
Severe ED: Lower response; combination therapy often required
Men who still respond partially to medications like sildenafil tend to have the highest success rates.
Schedule an Appointment
Medication Independence
One of the most clinically meaningful outcomes is reduced reliance on ED medication.
Studies suggest:
40–60% of men become less dependent on PDE-5 inhibitors
Many patients transition from non-responders to medication responders
(i.e., viagra starts working again )Some patients regain spontaneous erections without medication
This is why shockwave therapy is often described as a disease-modifying treatment rather than a symptomatic therapy.
Which Patients Have the Highest Success Rates?
Shockwave therapy is not a universal solution. Outcomes depend strongly on underlying physiology.
Ideal Candidates
Patients most likely to benefit include:
Vasculogenic erectile dysfunction
Early endothelial dysfunction
Mild to moderate ED
Men seeking restorative therapies to mitigate symptom progression
Patients with cardiovascular risk factors (hypertension, metabolic syndrome, diabetes in early stages)
Lower Response Groups
Reduced success rates are observed in men with:
Advanced diabetes with neuropathy
Severe arterial insufficiency
Post-radical prostatectomy nerve injury
Extensive pelvic radiation damage
Severe corporal fibrosis
In these cases, combination regenerative strategies may be recommended.
Treatment Protocol Matters
Not all shockwave therapy is equivalent.
Published success rates are tied to specific treatment parameters, including:
Energy density
Number of pulses
Treatment frequency
Total number of sessions
Device quality (focused vs radial systems)
Protocols used in clinical trials typically involve:
6–12 treatment sessions
Treatments spaced over several weeks
Gradual biologic improvement rather than immediate effect
Patients should be cautious of programs promising instant results after minimal treatment or using non-evidence-based machines.
You can learn more on our At-Home Shockwave Therapy for ED - Is It Effective blog post.
Schedule an Appointment
How Long Do Results Last?
Unlike medication-based therapies, shockwave therapy aims to create structural vascular improvement.
Long-term studies show:
Continued improvement at 12 months
Durable benefit in many patients at 24 months
Utilization of maintenance treatments maintains and improves results, especially if vascular risk factors progress
Because ED is often linked to systemic vascular aging, lifestyle and metabolic health remain critical to maintaining results.
Safety Profile
One reason shockwave therapy has gained widespread clinical interest is its favorable safety profile.
Clinical trials report:
Topical local anesthesia is optional
No downtime
Minimal discomfort
Extremely low complication rates
To date, serious adverse events have not been associated with properly administered low-intensity shockwave therapy.
Shockwave Therapy vs Traditional ED Treatments
Oral Medications
✓ Treats Symptoms
✗ Treats Root Cause
✗ Long-Term Improvement
Injections
✓ Treats Symptoms
✗ Treats Root Cause
✗ Long-Term Improvement
Vacuum devices
✓ Treats Symptoms
✗ Treats Root Cause
✗ Long-Term Improvement
Shockwave therapy
✓ Treats Symptoms
✓ Treats Root Cause
✓ Long-Term Improvement
This distinction explains why interest in shockwave therapy continues to grow among both patients and physicians.
The Realistic Takeaway on Success Rates
The most evidence-based summary is:
60–80% of properly selected men experience meaningful improvement
Best outcomes occur in vasculogenic, early-stage ED
Results develop gradually as tissue regeneration occurs
Shockwave therapy works best as part of a comprehensive men’s health strategy
For many patients, the goal is not simply achieving erections with assistance, but restoring and maintaining optimal erectile function.
Final Thoughts
Erectile dysfunction is increasingly understood as an early marker of vascular disease rather than an isolated sexual problem. Treatments that improve endothelial health (blood vessel health) may therefore play a central role in future sexual medicine.
Low-Intensity Shockwave Therapy represents one of the first non-invasive therapies aimed at reversing, not merely managing, erectile dysfunction. Although it’s considered investigational and not a standard of care treatment by the American and Canadian Urologic Societies, it is considered extremely safe and has a high efficacy rate in a properly selected patient population.
Contact our office if you’d like an evaluation and to discuss our comprehensive approach to treating ED.
